MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 841 to 860 of 166,322 approvalsPage 43 of 8317

Indobufen Tablets

Approval Number: 国药准字H20253852
Registration: Apr 8, 2025

Famotidine Injection

Approval Number: 国药准字H20253828
Registration: Apr 8, 2025

Ertapenem Sodium for Injection

Approval Number: 国药准字HJ20250040
Registration: Apr 8, 2025
m/s.gland pharma limited

Zoledronic Acid Injection

Approval Number: 国药准字H20253810
Registration: Apr 8, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253815
Registration: Apr 8, 2025

Ertapenem Sodium for Injection

Approval Number: 国药准字H20253836
Registration: Apr 8, 2025

Pemafibrate Tablets

Approval Number: 国药准字HJ20250041
Registration: Apr 8, 2025

Pravastatin Sodium Tablets

Approval Number: 国药准字H20253858
Registration: Apr 8, 2025

Cetylpyridinium Chloride Buccal Tablets

Approval Number: 国药准字H20253837
Registration: Apr 8, 2025

Levofloxacin Eye Drops

Approval Number: 国药准字H20253857
Registration: Apr 8, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253829
Registration: Apr 8, 2025

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20253859
Registration: Apr 8, 2025

Mercaptopurine Tablets

Approval Number: 国药准字H20253809
Registration: Apr 8, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20253819
Registration: Apr 8, 2025

Potassium Chloride Granules

Approval Number: 国药准字H20253851
Registration: Apr 8, 2025

Ropinirole Hydrochloride Sustained-release Tablets

Approval Number: 国药准字H20253817
Registration: Apr 8, 2025

Montmorillonite Suspension

Approval Number: 国药准字H20253808
Registration: Apr 8, 2025

Magnesium Sulfate Injection

Approval Number: 国药准字H20253824
Registration: Apr 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.